BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8341001)

  • 1. The relationship between early afterdepolarization and the occurrence of torsades de pointes--an in vivo canine model study.
    Sato T; Hirao K; Hiejima K
    Jpn Circ J; 1993 Jun; 57(6):543-52. PubMed ID: 8341001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insight into the mechanism of torsade de pointes (TDP) induced by cesium chloride].
    Shen JB; Huang J; Jiang WP
    Zhonghua Nei Ke Za Zhi; 1992 Jul; 31(7):407-9, 444. PubMed ID: 1338528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TU alternans, long QTU, and torsade de pointes: clinical and experimental observations.
    Habbab MA; el-Sherif N
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):916-31. PubMed ID: 1376904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apamin induces early afterdepolarizations and torsades de pointes ventricular arrhythmia from failing rabbit ventricles exhibiting secondary rises in intracellular calcium.
    Chang PC; Hsieh YC; Hsueh CH; Weiss JN; Lin SF; Chen PS
    Heart Rhythm; 2013 Oct; 10(10):1516-24. PubMed ID: 23835258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes?
    Satoh T; Zipes DP
    J Cardiovasc Electrophysiol; 1998 Sep; 9(9):970-5. PubMed ID: 9786077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
    Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR
    J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.
    Kurita T; Ohe T; Shimizu W; Hotta D; Shimomura K
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 1):33-8. PubMed ID: 7681173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early afterdepolarization and cesium chloride induced ventricular arrhythmias].
    Zheng LR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):369-71, 390. PubMed ID: 1307980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
    Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
    Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration-induced action potential prolongation and early afterdepolarizations.
    Burashnikov A; Antzelevitch C
    J Cardiovasc Electrophysiol; 1998 Sep; 9(9):934-48. PubMed ID: 9786074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
    Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
    Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs.
    Bailie DS; Inoue H; Kaseda S; Ben-David J; Zipes DP
    Circulation; 1988 Jun; 77(6):1395-402. PubMed ID: 3370776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models of torsades de pointes.
    Weissenburger J; Davy JM; Chézalviel F
    Fundam Clin Pharmacol; 1993; 7(1):29-38. PubMed ID: 8458600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of drug-induced torsade de pointes: an experimental study in dogs].
    Wang J; Yu Z; Cui C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1093-6. PubMed ID: 23895862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of flunarizine and ryanodine on acquired torsades de pointes arrhythmias in the intact canine heart.
    Verduyn SC; Vos MA; Gorgels AP; van der Zande J; Leunissen JD; Wellens HJ
    J Cardiovasc Electrophysiol; 1995 Mar; 6(3):189-200. PubMed ID: 7620644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
    Yamamoto K; Tamura T; Imai R; Yamamoto M
    Toxicol Sci; 2001 Mar; 60(1):165-76. PubMed ID: 11222883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
    Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of early afterdepolarization induced by cesium chloride in mouse atrial and ventricular fibers.
    Zhou YY; Liu TF
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):261-5. PubMed ID: 7660824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.